Commentary
Nonfasting lipid testing: the new standard for cardiovascular risk assessment
Pol Darras, Andre Mattman and Gordon A. Francis
CMAJ November 12, 2018 190 (45) E1317-E1318; DOI: https://doi.org/10.1503/cmaj.180804
Pol Darras
Division of Endocrinology and Metabolism (Darras, Francis), Department of Medicine; Department of Pathology and Laboratory Medicine (Mattman), and Centre for Heart Lung Innovation (Francis), St. Paul’s Hospital, University of British Columbia, Vancouver, BC
MDAndre Mattman
Division of Endocrinology and Metabolism (Darras, Francis), Department of Medicine; Department of Pathology and Laboratory Medicine (Mattman), and Centre for Heart Lung Innovation (Francis), St. Paul’s Hospital, University of British Columbia, Vancouver, BC
MDGordon A. Francis
Division of Endocrinology and Metabolism (Darras, Francis), Department of Medicine; Department of Pathology and Laboratory Medicine (Mattman), and Centre for Heart Lung Innovation (Francis), St. Paul’s Hospital, University of British Columbia, Vancouver, BC
MDIn this issue
Article tools
Nonfasting lipid testing: the new standard for cardiovascular risk assessment
Pol Darras, Andre Mattman, Gordon A. Francis
CMAJ Nov 2018, 190 (45) E1317-E1318; DOI: 10.1503/cmaj.180804
Related Articles
- No related articles found.